Slide 1 DEBATE: Do we have enough data to eliminate chemotherapy from initial CLL therapy? Can kinase inhibitors and IMiDs replace chemotherapy? Jennifer R Brown, MD PhD…

Slide 1 A NTIMICROBIAL S TEWARDSHIP What’s In It For YOU! Paul Pottinger, MD, DTM&H Director, UWMC Antimicrobial Stewardship Program February 11, 2014 Slide 2 Show…

Slide 1 A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized unresectable pancreatic cancer:…

Slide 1 The role of trophic factors in chemotherapy- induced peripheral neuropathies Roma 22 giugno 2006 Guido Cavaletti Department of Neurosciences and Biomedical Technologies…

Slide 1 1 Clinical Safety & Effectiveness Session # 7 Venous Thromboembolism Prophylaxis DATE Educating for Quality Improvement & Patient Safety Slide 2 2 What We…

RANDOMIZED PHASE II TRIAL COMPARING FOLFIRINOX (5FU/LEUCOVORIN, IRINOTECAN AND OXALIPLATIN) VS GEMCITABINE AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA…

Health Psychology Service GSTFT Sickle Cell Disease: Approaches to Pain Management Building Sustainable Services Dr Veronica ( Nicky) Thomas Consultant Health Psychologist…

Health Psychology Service GSTFT Sickle Cell Disease: Approaches to Pain Management Building Sustainable Services Dr Veronica ( Nicky) Thomas Consultant Health Psychologist…

Objectives To highlight the key presentations in Breast Cancer To provide clinical context for these presentations To discuss clinical implications of this data Key Highlights…

RANDOMIZED PHASE II TRIAL COMPARING FOLFIRINOX (5FU/LEUCOVORIN, IRINOTECAN AND OXALIPLATIN) VS GEMCITABINE AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA…